Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€2.30
17.06.20
€5.00
04.11.21
73.91%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
High valuation
buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€8.40
09.08.21
€13.00
09.08.22
42.86%
10.08.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Few uniques
buy
Dynatronics Corp

Start price
Target price
Perf. (%)
€1.07
26.07.21
€2.50
26.07.22
-1.87%
07.08.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.45
23.09.20
-
04.11.21
-47.51%
15.07.21

Probably not worthwhile Investment
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€4.53
02.07.21
-
02.07.22
18.90%
13.07.21

Risky Investment
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€7.20
25.06.21
-
25.06.22
-26.39%
30.06.21

Could be very worthwhile Investment >20% year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.30
02.06.21
-
02.06.22
9.09%
20.06.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.70
02.05.21
-
02.05.22
1.08%
16.05.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€12.90
17.10.20
-
04.11.21
-29.07%
24.03.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.22
21.02.21
-
21.02.22
-5.21%
06.03.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.12
08.02.21
€5.00
08.02.22
14.10%
22.02.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.44
08.02.21
€5.00
08.02.22
-27.31%
22.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€36.75
25.01.21
€50.00
25.01.22
-12.24%
08.02.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€2.10
25.01.21
€3.00
25.01.22
63.56%
08.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.79
11.01.21
€2.00
11.01.22
166.14%
25.01.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.72
14.12.20
€2.00
14.12.21
9.69%
11.01.21

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.36
13.12.20
-
13.12.21
-5.96%
10.01.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
19.09.20
-
29.09.20
72.97%
29.09.20

High risks for its business
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
21.09.20
-
28.09.20
40.54%
28.09.20

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
19.09.20
-
23.09.20
34.46%
23.09.20

Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€4.94
06.09.20
-
19.09.20
49.80%
19.09.20

High risks for its business
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.20
03.09.20
-
03.09.20
-
03.09.20

High risks for its business